https://www.gilead.com/news/news-details/2025/trodelvy-plus-keytruda-reduces-risk-of-disease-progression-or-death-by-35-versus-keytruda-and-chemotherapy-in-first-line-pd-l1-metastatic-triple-negative-breast-cancer Ohm20,